January 18, 2000Teva Pharmaceuticals Recalls
Diltiazem Hydrochloride Extended Release Capsules
Sellersville, PA (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Teva Pharmaceuticals USA is recalling 120 mg
Diltiazem Hydrochloride Extended Release Capsules because of dissolution failure at 3
The recalled product, indicated for
angina pectoris due to coronary artery spasms, was distributed in in 100-capsule
bottles. The product can be identified by the lot number 11829 and expiration date
According to FDA, only 9,500 bottles
were distributed Nationwide.
This ongoing Class III recall
was initiated by Teva Pharmaceuticals by letter on December 23, 1999. This is the
first public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #D-200-0
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.